Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Noripharma is a prominent Malaysian pharmaceutical company specializing in the manufacturing and marketing of generic pharmaceutical products. Established in 2002, the company has grown to become a key supplier of essential medicines to both the public and private healthcare sectors in Malaysia. Its product portfolio spans multiple therapeutic categories, including cardiovascular, respiratory, gastrointestinal, and anti-infective treatments. The company operates a modern, GMP-certified manufacturing facility in Rawang, Selangor, which is equipped to produce various dosage forms such as tablets, capsules, and liquids. In addition to its domestic operations, Noripharma actively exports its products to international markets in Southeast Asia and beyond. The company also offers contract manufacturing and packaging services to global pharmaceutical partners seeking a manufacturing base in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Noripharma.